Cerebral Stroke Clinical Trial
Official title:
Facilitating Implicit Learning to Improve Neurorehabilitation in Stroke
Verified date | April 2016 |
Source | VA Office of Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
Stroke is one of the leading causes of chronic disability in Veterans. Stroke is associated with significant loss of mobility, increased risk of falling, cardiovascular disease, depression and neuro-cognitive impairment. These deficits negatively impact the independent completion of the Activities of Daily Living (ADLs). Task-oriented training has emerged as the dominant therapeutic intervention in the rehabilitation of chronic stroke victims. The effectiveness of these interventions may be enhanced through facilitation of implicit knowledge rather than explicit knowledge. Specifically, implicit learning increases retention and improves transfer of the improved motor function outside of the lab environment. Moreover, implicit motor control reduces the burden imposed on cognitive resources as the skill is performed automatically (i.e. do not have to 'think' about it). The amount and type of feedback individuals receive while learning a new task (or relearning in the case of rehabilitation) has been shown to influence the type of learning (i.e. implicit or explicit). Thus the purpose of the current study is to determine the effect of different types of feedback during motor learning on the learning type and the resultant impact on functional outcomes (i.e. motor performance, retention, and cognitive workload) in chronic stroke patients.
Status | Active, not recruiting |
Enrollment | 30 |
Est. completion date | September 2016 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 45 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Ischemic stroke greater than 3 months prior. - Between 45 and 80 years of age. - Residual hemiparetic upper extremity deficits. - Adequate language and neurocognitive function to participate in training (MMSE, CESD, aphasia screening). - Right hand dominant. - Upper Extremity Fugl-Meyer score of 25 or greater. Exclusion Criteria: - History of cortical stroke. - No mobility of less affected arm. - Failure to meet the RRDC assessment clinic criteria for medical eligibility. - MMSE score less than 27. - CES-D score greater than 16. - Unable to pass a hearing test (i.e. must be able to hear sounds of 45 dB or less). |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
United States | Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD | Baltimore | Maryland |
Lead Sponsor | Collaborator |
---|---|
VA Office of Research and Development |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Motor Performance | Quality of motor behavior | 2 Years | No |
Secondary | EEG derived event related potential | Brain electrophysiology measure of attentional processes | 2 Years | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT03685578 -
CERENOVUS Neurothrombectomy Devices Registry
|
||
Recruiting |
NCT05591183 -
CERENOVUS Neurothrombectomy Devices Registry
|
||
Completed |
NCT04465019 -
Exoskeleton Rehabilitation on TBI
|
||
Completed |
NCT02827825 -
Patients Undergoing Strokes Admitted in Intensive Care Requiring Neurosurgical ICU Crossing: Patient Profile and Prognosis
|
||
Recruiting |
NCT02077582 -
Longitudinal MRI Examinations of Patients With Brain Ischemia and Blood Brain Barrier Permeability
|
N/A | |
Completed |
NCT01732679 -
Sunnaas International Network´s Stroke Study
|
N/A | |
Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
Completed |
NCT00311025 -
Stroke: Reduction of Physical Performance Post Stroke. Inactivity or Secondary Complications?
|
Phase 1/Phase 2 | |
Withdrawn |
NCT03804125 -
A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
|
||
Completed |
NCT05435404 -
Qualitative Study Patient & Physician Experiences Botox COVID-19
|
||
Completed |
NCT03898960 -
Post Marketing Study to Evaluate the NIMBUS Device
|
||
Not yet recruiting |
NCT06087094 -
A Trial of HRS-7450 in Chinese Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02207023 -
Healthy Lifestyles After Stroke - Stroke Coach
|
N/A | |
Completed |
NCT02002390 -
Efficacy and Safety of FTY720 for Acute Stroke
|
Phase 2 | |
Completed |
NCT01864382 -
"Core Stability" Exercises to Improve Sitting Balance in Stroke Patients
|
N/A | |
Recruiting |
NCT04447599 -
Conjunctival and Retinal Vascularization and Small Vessel Disease
|
N/A | |
Recruiting |
NCT04157179 -
Cerebral Oxygen Metabolism in Children
|
N/A | |
Completed |
NCT03417349 -
Safety and Effectiveness of SOFIA™/SOFIA™ PLUS for Direct Aspiration in Acute Ischemic Stroke
|